Want to see ACMR full AI Analyst Report?
Top Page
ACM Research
(NASDAQ:ACMR)
Select Model
Select Model
Rating:66Neutral
Price Target:
$91.00
▲(7.92% Upside)
Action:Reiterated
Date:08/08/26
The score is driven primarily by solid fundamentals (growth and a strong, low-leverage balance sheet) and a constructive earnings update with raised guidance and strong order momentum. Offsetting these positives are elevated cash-flow risk (negative OCF/FCF), a relatively expensive valuation (high P/E with no dividend support), and mixed/weak technical momentum (negative MACD and below the 50-day average).
Positive Factors
Robust revenue and order momentum
Sustained top-line acceleration and a 105% H1 order surge indicate durable end-market demand and a growing backlog. This improves near-term revenue visibility, supports multi-quarter production planning, and underpins capacity investments and margin leverage as shipments convert over the typical multi-month delivery cycle.
Negative Factors
Negative operating and free cash flow
Persistent negative OCF and FCF despite reported profits indicate earnings are not converting to cash, driven by heavy working-capital and capex demands. Over a 2–6 month horizon this elevates execution risk, could constrain discretionary spending, and increases the probability of future equity raises or higher leverage if demand or collections weaken.
Read all positive and negative factors
Positive Factors
Negative Factors
Robust revenue and order momentum
Sustained top-line acceleration and a 105% H1 order surge indicate durable end-market demand and a growing backlog. This improves near-term revenue visibility, supports multi-quarter production planning, and underpins capacity investments and margin leverage as shipments convert over the typical multi-month delivery cycle.
Read all positive factors
ACM Research Key Performance Indicators (KPIs)
Any
Revenue by Product
Breaks down revenue by each product line, highlighting which products drive the most sales and indicating areas of potential growth or concern based on market demand and product performance.
Breaks down revenue by each product line, highlighting which products drive the most sales and indicating areas of potential growth or concern based on market demand and product performance.
Data provided by:
The Fly
The FlyACM Research (ACMR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.66B
Dividend YieldN/A
Average Volume (3M)1.51M
Price to Earnings (P/E)36.1
Beta (1Y)1.70
Revenue Growth27.31%
EPS Growth26.90%
CountryUS
Employees2,513
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)2.25
Shares Outstanding64,657,390
10 Day Avg. Volume887,511
30 Day Avg. Volume1,510,936
Financial Highlights & Ratios
PEG Ratio-2.24
Price to Book (P/B)1.73
Price to Sales (P/S)2.81
P/FCF Ratio-38.01
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$129.75Price Target Upside53.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.16
Revenue Forecast (FY)$1.17B
ACM Research Business Overview & Revenue Model
Company Description
ACM Research, Inc., along with its affiliated companies, is a global developer, manufacturer, and provider of specialized single-wafer wet cleaning systems. These crucial systems are designed to enhance manufacturing processes and improve the yiel...
How the Company Makes Money
ACM Research primarily makes money by selling semiconductor capital equipment to chipmakers and foundries, with revenue recognized from the delivery/acceptance of its process tools used in wafer manufacturing. Its core revenue stream is product sa...
ACM Research Earnings Call Summary
Earnings Call Date:Aug 07, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 11, 2026
Earnings Call Sentiment Positive
The call conveyed strong demand with clear execution momentum: robust revenue and shipment growth (both +36% YoY), substantial order intake (+105% H1), rapid adoption of plating technology (2,000 chambers shipped), improved liquidity (net cash ~$1.0B) and upgraded FY2026 guidance. Management highlighted multiple commercialization milestones (panel-level plating orders, PECVD and Track evaluations), manufacturing capacity expansion (Lingang and Oregon) and broadened customer base. Offsetting risks include a 14.2% decline in single-wafer cleaning revenue to date (pending SPM qualification), elevated inventory of tools under evaluation, supply-chain/component lead-time constraints that could shift shipments between quarters, a modest YoY contraction in gross margin to 46%, higher operating/capex spend and a larger tax expense this quarter. Overall, the positives — strong orders, multi-product progress, balance-sheet strength and raised guidance — materially outweigh the execution and timing headwinds.Positive Updates
Strong Top-Line Growth
Revenue of $292.9M in Q2 up 36% year-over-year; total shipments $281.5M, also up 36.4% YoY.
Negative Updates
Decline in Single-Wafer Cleaning Revenue
Single-wafer cleaning, Tahoe and semi-critical cleaning revenue was $133.0M, down 14.2% YoY and still ~45.4% of sales; new SPM products have had very little revenue contribution to date (revenue lag behind shipments/qualification).
Read all updates
Q2-2026 Updates
Positive
Negative
Strong Top-Line Growth
Revenue of $292.9M in Q2 up 36% year-over-year; total shipments $281.5M, also up 36.4% YoY.
Read all positive updates
Company Guidance
ACM updated full‑year 2026 guidance to $1.125–$1.175 billion in revenue (upside from prior $1.08B low end), implying ~25–30% YoY growth, and said shipments will outpace revenue; H1 orders rose 105% YoY while Q2 revenue and shipments were $292.9M and $281.5M (both ~+36% YoY), Q2 gross margin was 46% (long‑term target 42–48%) and operating margin ~19% (19.2%); balance sheet/cash metrics include gross cash $1.4B, net cash $1.0B (≈$300M in the U.S.), cash & equivalents $1.36B, inventory $783.1M (raw $406.1M, WIP $89.0M, finished $287.9M); OpEx was $78.5M (R&D 13.9% of sales with a 2026 plan of 16–18%, S&M ~7.7% with an ~8% plan, G&A 5.2% with 5–6% plan), tax rate guidance 10–12%, CapEx guide ≈$175M for 2026 (Q2 CapEx $65.4M), and management reiterated a $4B long‑term revenue target (≈$2.5B China / $1.5B global) while increasing SAM to about $22B.ACM Research Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
34
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.04B | 901.31M | 782.12M | 557.72M | 388.83M | 259.75M |
| Gross Profit | 454.91M | 400.07M | 391.55M | 276.21M | 183.62M | 114.86M |
| EBITDA | 270.43M | 158.47M | 180.42M | 126.99M | 74.38M | 46.17M |
| Net Income | 150.23M | 94.08M | 103.63M | 77.35M | 39.26M | 37.76M |
Balance Sheet | ||||||
| Total Assets | 3.40B | 2.87B | 1.86B | 1.49B | 1.24B | 1.05B |
| Cash, Cash Equivalents and Short-Term Investments | 1.46B | 1.17B | 444.10M | 283.93M | 338.65M | 592.05M |
| Total Debt | 349.32M | 302.98M | 188.78M | 99.10M | 79.50M | 39.14M |
| Total Liabilities | 994.12M | 941.68M | 759.82M | 564.75M | 423.33M | 240.51M |
| Stockholders Equity | 1.86B | 1.46B | 904.63M | 767.39M | 674.86M | 676.20M |
Cash Flow | ||||||
| Free Cash Flow | -120.13M | -66.61M | 69.99M | -139.66M | -154.71M | -49.80M |
| Operating Cash Flow | -6.60M | -10.32M | 152.45M | -75.32M | -62.19M | -40.09M |
| Investing Cash Flow | -438.52M | -390.33M | -11.96M | -6.75M | -265.67M | -11.28M |
| Financing Cash Flow | 964.11M | 742.49M | 92.48M | 18.53M | 45.87M | 538.77M |
ACM Research Technical Analysis
Positive
84.32
Price Trends
90.89
Negative
73.87
Positive
59.96
Positive
Market Momentum
-2.87
Negative
47.23
Neutral
40.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACMR, the sentiment is Positive. The current price of 84.32 is above the 20-day moving average (MA) of 81.20, below the 50-day MA of 90.89, and above the 200-day MA of 59.96, indicating a neutral trend. The MACD of -2.87 indicates Negative momentum. The RSI at 47.23 is Neutral, neither overbought nor oversold. The STOCH value of 40.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ACMR.
ACM Research Risk Analysis
ACM Research disclosed 61 risk factors in its most recent earnings report. ACM Research reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
ACM Research Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $4.98B | 43.35 | 13.55% | 0.81% | 44.44% | 2283.94% | |
68 Neutral | $4.39B | 47.68 | 8.91% | ― | -3.35% | -38.92% | |
67 Neutral | $10.06B | 88.97 | 10.96% | ― | 18.01% | 161.14% | |
66 Neutral | $5.66B | 36.08 | 9.48% | ― | 27.31% | 26.90% | |
65 Neutral | $3.26B | 139.86 | 2.62% | ― | -2.52% | -64.30% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
53 Neutral | $4.10B | -178.67 | -3.48% | ― | 2.53% | 84.78% |
* Technology Sector Average
ACMR
ACM Research
80.42
55.40
221.42%
ACLS
Axcelis Technologies
140.15
59.64
74.08%
FORM
Formfactor
131.60
102.90
358.54%
KLIC
Kulicke & Soffa
99.09
63.50
178.38%
UCTT
Ultra Clean Holdings
84.93
62.26
274.64%
VECO
Veeco
52.40
28.58
119.98%
ACM Research Corporate Events
Business Operations and StrategyFinancial Disclosures
ACM Research Highlights Strong Order Growth and Guidance
Positive
Jun 22, 2026
On June 16, 2026, ACM Research (Shanghai), Inc. held an investor relations event in Shanghai, where management reported that newly signed orders rose 65% year over year in the first quarter of 2026 and reaffirmed full-year revenue guidance of RMB ...
Executive/Board ChangesShareholder Meetings
ACM Research Shareholders Back Governance Structure and Board
Positive
Jun 12, 2026
At ACM Research’s 2026 Annual Meeting of Stockholders, held on June 10, 2026, shareholders of the company’s Class A and Class B common stock voted on two proposals, with 84.32% of total voting power represented in person or by proxy. T...
Business Operations and StrategyDelistings and Listing ChangesPrivate Placements and Financing
ACM Research’s Shanghai Unit Plans Hong Kong Listing
Positive
May 29, 2026
On May 26, 2026, ACM Research (Shanghai), Inc. announced that its board unanimously approved a plan to offer H shares and seek a secondary listing on the Main Board of the Hong Kong Stock Exchange. The proposal, which still requires shareholder an...
Business Operations and StrategyFinancial Disclosures
ACM Research Highlights Q1 Orders Surge and Tech Progress
Positive
May 22, 2026
ACM Research (Shanghai), Inc. held an earnings conference call on May 14, 2026, to review its first-quarter 2026 operating results and financial condition for investors, with the Record of the event later posted by the Shanghai Stock Exchange on M...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
ACM Research Raises Capital Through Registered Direct Stock Offering
Positive
May 15, 2026
ACM Research, Inc. completed a registered direct offering of 2,884,615 shares of its Class A common stock on May 15, 2026, following a Securities Purchase Agreement it entered into with certain investors on May 12, 2026. The shares were sold at $5...
Business Operations and StrategyPrivate Placements and Financing
ACM Research Announces $150 Million Direct Share Offering
Positive
May 12, 2026
On May 12, 2026, ACM Research, Inc. entered into a securities purchase agreement with U.S. institutional investors managed by Tekne Capital Management for a registered direct offering of 2,884,615 Class A common shares at $52.00 per share. The com...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.